Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
Authors
Keywords
-
Journal
Stem Cells Translational Medicine
Volume 2, Issue 4, Pages 274-283
Publisher
Wiley
Online
2013-03-21
DOI
10.5966/sctm.2012-0084
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR
- (2012) H. Torikai et al. BLOOD
- Embryonic stem cell trials for macular degeneration: a preliminary report
- (2012) Steven D Schwartz et al. LANCET
- The promise of induced pluripotent stem cells in research and therapy
- (2012) Daisy A. Robinton et al. NATURE
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
- (2010) S. Cooley et al. BLOOD
- Human embryonic stem cell-derived CD34+ cells function as MSC progenitor cells
- (2010) Ross A. Kopher et al. BONE
- Human embryonic stem cell−derived vascular progenitor cells capable of endothelial and smooth muscle cell function
- (2010) Katherine L. Hill et al. EXPERIMENTAL HEMATOLOGY
- Human Pluripotent Stem Cells Produce Natural Killer Cells That Mediate Anti-HIV-1 Activity by Utilizing Diverse Cellular Mechanisms
- (2010) Z. Ni et al. JOURNAL OF VIROLOGY
- Pluripotent stem cell-derived natural killer cells for cancer therapy
- (2010) David A. Knorr et al. Translational Research
- Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells
- (2009) D. S. Kaufman BLOOD
- Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity
- (2009) P. S. Woll et al. BLOOD
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
- (2009) H. Fujisaki et al. CANCER RESEARCH
- The promise and potential pitfalls of chimeric antigen receptors
- (2009) Michel Sadelain et al. CURRENT OPINION IN IMMUNOLOGY
- Generation of T Cells from Human Embryonic Stem Cell-Derived Hematopoietic Zones
- (2009) F. Timmermans et al. JOURNAL OF IMMUNOLOGY
- Bioluminescent Imaging Demonstrates That Transplanted Human Embryonic Stem Cell-Derived CD34+Cells Preferentially Develop into Endothelial Cells
- (2009) Xinghui Tian et al. STEM CELLS
- Hematopoietic and endothelial differentiation of human induced pluripotent stem cells
- (2009) Kyung-Dal Choi et al. STEM CELLS
- Efficient Hematopoietic Differentiation of Human Embryonic Stem Cells on Stromal Cells Derived from Hematopoietic Niches
- (2008) Maria H. Ledran et al. Cell Stem Cell
- A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies
- (2008) Elizabeth S Ng et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now